| Trial ID: | L0639 |
| Source ID: | IRCT2013071313069N2
|
| Associated Drug: |
Metformin
|
| Title: |
Comparison of therapeutic effects of metformin, pioglitazone and vitamin E on nonalcoholic fatty liver disease patients
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Group A:Tablet metformine 2gr/day orally (two 500 mg tablets q 12h) for 12 weeks. Intervention 2: Group B: Tablet pioglitazone 30 mg/day orally ( one 15 mg tablet q 12h) for 12 weeks. Intervention 3: Group C: Tablet vitamin E 800 IU/day o
|
| Outcome Measures: |
Liver enzymes, Blood sugar, Insulin. Timepoint: Before and 12 weeks after treatment. Method of measurement: Laboratory assessment (ELISA).Liver echo pattern. Timepoint: Before and 12 weeks after treatment. Method of measurement: Sonographic assessment.
|
| Sponsor/Collaborators: |
Vice chancellor for research, Kermanshah University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years80 years
|
| Phases: |
Phase 3
|
| Enrollment: |
93
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Patients randomized into study groups by 1:1 ratio method using a computer-generated random numbers?. Physician who ev
|
| Start Date: |
22/09/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/13006
|
